|
|
|
|
NobleCon16 Panel to Discuss Cannabis Regulatory Future, Industry Trends, and Expectations for Investors
(Note: companies that
could be impacted by the content of this article are listed at the base of the
story [desktop version]. This article uses third-party references to provide a
bullish, bearish, and balanced point of view; sources are listed after the
Balanced section.)
If cannabis and hemp products are expected to take a larger role in people’s day-to-day lives, why were stock prices so depressed last year? What will signal the expected rebound?
These questions, along with current regulations and the implications of new statutes, on both the state and federal level, are to be weighed and discussed by a diversified panel of experts. The panel boasts a variety of professionals who are involved in different areas of the fledgling business. These presenters were hand-selected for their ability to bring a complete mix of up-to-date information that will attempt to touch on all the different issues impacting their industry. The goal is for the investors attending NobleCon16 to develop a better understanding of the direction and pace of the cannabis industry this decade.
The discussion will take place at NobleCon16 being held from February 16th – 18th at the Hard Rock Guitar
Hotel in Fort Lauderdale.
The Panelists:
The panelists have been pulled from VC funds, CBD companies, an industry news and information publisher, specialized lawyer, supply chain expert, and a provider of industry staffing and education. Back Down to Reality? What
Investors Should Know About Cannabis Stocks in 2020 will take place on Monday, February 17 at 5:30pm.
Arby Barroso, Co-founder at Green Roads World
Brett Finkelstein, Managing Director at Phyto
Partners, LP
Jason Spatafora, Owner at MarijuanaStocks.com
Jonathan Conforti, Vice President of Corporate Development, Abacus Health Products, Inc.
Matt Ginder, Partner at Greenspoon Marder, LLP
Roman Bond, Founder at The Leafy Group
Robert Friedman (Moderator), Founder at Cannabis Labs
Brett Heimann, the Director at Noble responsible for orchestrating this highly regarded cannabis panel had this to say: “I think people should view the cannabis industry, as it relates to CBD products, the way cell phones were viewed twenty years ago. At first, a few early-adopters saw the benefits of having a “cellular phone” available to them. Two decades, and some significant evolution to the offerings, and almost everyone now finds the phones indispensable. CBD in households could easily become as commonplace as aspirin.”
Level With Me
In addition to Back Down to
Reality? What Investors Should Know About Cannabis Stocks in 2020, Noble Capital Markets has assembled many information-packed company presentations and addresses for their 16th conference. The events should be of interest to anyone seeking to discover still-small companies whose businesses could soon have a bigger impact.
NobleCon conferences experience 70% repeat attendance by investors who want to build on their understanding of opportunities and perhaps meet privately with company management to best understand their company’s potential. Money managers, family office finance professionals, investment advisors, independent brokers, and equity analysts go to NobleCon each year to learn of companies, products, and breakthroughs that could easily be overlooked in a world where larger well-known companies get the majority of the spotlight. Some of tomorrow’s household names are companies that benefit from more light being shed on them today. That’s what NobleCon and ChannelChek are about — Shedding more light on small and micro-cap opportunities in order to unearth actionable ideas.
More Information: